Literature DB >> 30664976

Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery.

Ying Qu1, Bingyang Chu1, Xiawei Wei1, Minyi Lei1, Danrong Hu1, Ruoyu Zha1, Lin Zhong1, Mengyao Wang1, Fangfang Wang1, Zhiyong Qian2.   

Abstract

At present, chemotherapy remains to be one of the most important therapeutic approaches for malignant tumors. The tumor microenvironment(TME)-responsive intelligent drug delivery systems are still the hot research topics in delivering chemotherapeutic drugs. Camptothecin (CPT) possesses very strong antitumor activities, but its clinical application is hindered by its poor water-solubility and serious toxic side effects. Herein, a new intelligent and TME-responsive P(CPT-MAA) prodrug nanogel was developed for delivering CPT and reducing its side effects. P(CPT-MAA) prodrug nanogels were prepared with methacrylic acid (MAA), CPT monomer (CPTM) and N,N'-methylenebisacrylamide (Bis) via distillation-precipitation polymerization, in which CPT was covalently conjugated into the nanogels via redox-responsive disulfide linker. The as-prepared nanogels were spherical shapes with uniform size and narrow size distribution. With the help of redox-responsive property of disulfide linker and pH-responsive property of PMAA, the release of CPT from prodrug nanogels was redox/pH-dual dependent and could be accelerated by the increased concentration of GSH and the decreased pH value, which were favorable to realize the "on-demand" drug release in tumor cell and tumor tissue microenvironment. Furthermore, P(CPT-MAA) prodrug nanogels exhibited superior antitumor activity both in vitro and in vivo without observed side effects. Hence, the prepared P(CPT-MAA) prodrug nanogels may be a promise delivery system for chemotherapeutic agents.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Camptothecin; Cancer therapy; Prodrug nanogels; Redox-responsive; pH-responsive

Mesh:

Substances:

Year:  2019        PMID: 30664976     DOI: 10.1016/j.jconrel.2019.01.016

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  8 in total

Review 1.  Smart nanomaterials for cancer diagnosis and treatment.

Authors:  Ragini Singh; Ayush Sharma; Joel Saji; Akhela Umapathi; Santosh Kumar; Hemant Kumar Daima
Journal:  Nano Converg       Date:  2022-05-15

2.  Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma.

Authors:  Ying Liu; Yu Han; Shizhu Chen; Jingjie Liu; Dajiang Wang; Yifei Huang
Journal:  Acta Pharm Sin B       Date:  2021-10-22       Impact factor: 14.903

3.  Cryptobiosis-inspired assembly of "AND" logic gate platform for potential tumor-specific drug delivery.

Authors:  Hu Zhou; Gang He; Yanbin Sun; Jingguo Wang; Haitao Wu; Ping Jin; Zhengbao Zha
Journal:  Acta Pharm Sin B       Date:  2020-08-25       Impact factor: 11.413

4.  Galactosed and Reduction-Responsive Nanoparticles Assembled from Trimethylchitosan-Camptothecin Conjugates for Enhanced Hepatocellular Carcinoma Therapy.

Authors:  Chen Fu; Jingcan Qin; Xinlong Liu; Fei Kong
Journal:  Pharmaceutics       Date:  2022-06-21       Impact factor: 6.525

5.  Tumor-targeted/reduction-triggered composite multifunctional nanoparticles for breast cancer chemo-photothermal combinational therapy.

Authors:  Yun Yang; Danrong Hu; Yi Lu; Bingyang Chu; Xinlong He; Yu Chen; Yao Xiao; Chengli Yang; Kai Zhou; Liping Yuan; Zhiyong Qian
Journal:  Acta Pharm Sin B       Date:  2021-09-10       Impact factor: 14.903

6.  Nanogels as target drug delivery systems in cancer therapy: A review of the last decade.

Authors:  Anthony A Attama; Petra O Nnamani; Ozioma B Onokala; Agatha A Ugwu; Adaeze L Onugwu
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

Review 7.  Traditional Chinese Medicine and Colorectal Cancer: Implications for Drug Discovery.

Authors:  Qiang Sun; Man He; Meng Zhang; Sha Zeng; Li Chen; Hui Zhao; Han Yang; Maolun Liu; Shan Ren; Haibo Xu
Journal:  Front Pharmacol       Date:  2021-07-01       Impact factor: 5.810

8.  Bio-Orthogonal Nanogels for Multiresponsive Release.

Authors:  Mohammad Shafee Alkanawati; Marina Machtakova; Katharina Landfester; Héloïse Thérien-Aubin
Journal:  Biomacromolecules       Date:  2021-06-15       Impact factor: 6.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.